Literature DB >> 9386960

Modeling the effects of combined behavioral and pharmacological treatment on cigarette smoking: behavioral-economic analyses.

W K Bickel1, G J Madden, R J DeGrandpre.   

Abstract

Effects of different response requirements, response-independent cigarette puffs, and an alternative nondrug reinforcer on cigarette smoking were assessed in 2 experiments. The response requirement to obtain 2 puffs on a cigarette was manipulated while various numbers of response-independent puffs were provided (0, 6, or 12 in Experiment 1; 0 or 12 in Experiment 2). In Experiment 2, effects of response-dependent money ($0.25) on smoking were assessed within subjects. Response-dependent puff consumption decreased as price increased and as the number of response-independent puffs increased. Concurrently available money also decreased response-dependent smoking. The largest decrease in smoking occurred when puffs were at the highest price and when response-independent puffs and response-dependent money were both concurrently available. Findings suggest that combined pharmacological and behavioral interventions produce the greatest reductions in smoking.

Mesh:

Year:  1997        PMID: 9386960     DOI: 10.1037//1064-1297.5.4.334

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  14 in total

1.  The airway sensory impact of nicotine contributes to the conditioned reinforcing effects of individual puffs from cigarettes.

Authors:  Nasir H Naqvi; Antoine Bechara
Journal:  Pharmacol Biochem Behav       Date:  2005-08       Impact factor: 3.533

2.  Increasing the Value of an Alternative Monetary Reinforcer Reduces Cigarette Choice in Adolescents.

Authors:  Rachel N Cassidy; Jennifer W Tidey; Christopher W Kahler; Tyler B Wray; Suzanne M Colby
Journal:  Nicotine Tob Res       Date:  2015-02-08       Impact factor: 4.244

3.  The behavioral economics and neuroeconomics of reinforcer pathologies: implications for etiology and treatment of addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

4.  Effects of the combination of wheel running and atomoxetine on cue- and cocaine-primed reinstatement in rats selected for high or low impulsivity.

Authors:  Natalie E Zlebnik; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2014-09-26       Impact factor: 4.530

5.  Reinforcing effects of smoked methamphetamine in rhesus monkeys.

Authors:  Jennifer L Newman; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2006-08-26       Impact factor: 4.530

6.  Relative reinforcing efficacy of cigarettes as a predictor of smoking abstinence among treatment-seeking smokers.

Authors:  Roberto Secades-Villa; Irene Pericot-Valverde; Sara Weidberg
Journal:  Psychopharmacology (Berl)       Date:  2016-06-20       Impact factor: 4.530

Review 7.  Human nicotine conditioning requires explicit contingency knowledge: is addictive behaviour cognitively mediated?

Authors:  Lee Hogarth; Theodora Duka
Journal:  Psychopharmacology (Berl)       Date:  2005-09-21       Impact factor: 4.530

8.  Novel Therapeutics for Addiction: Behavioral and Neuroeconomic Approaches.

Authors:  Warren K Bickel; Alexandra M Mellis; Sarah E Snider; Lara Moody; Jeffrey S Stein; Amanda J Quisenberry
Journal:  Curr Treat Options Psychiatry       Date:  2016-07-02

9.  Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.

Authors:  Scott H Kollins; Joseph S English; Michelle E Roley; Benjamin O'Brien; Justin Blair; Scott D Lane; F Joseph McClernon
Journal:  Psychopharmacology (Berl)       Date:  2012-12-18       Impact factor: 4.530

10.  Temporal horizons of cigarette satiety: determining the window of time over which recent smoking influences motivation to smoke.

Authors:  Benjamin P Kowal; Warren K Bickel; Reid D Landes
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.